Inhibitory effect of three C-glycosylflavonoids from Cymbopogon citratus (lemongrass) on human low density lipoprotein oxidation

Molecules

Volumn 14, Issue 10, 2009, Pages 3906-3913

  Orrego, Roxana ^a   Leiva, Elba ^a   Cheel, José ^b  

^a UNIVERSIDAD DE TALCA   (Chile)

^b Charles University in Prague Faculty of Pharmacy   (Czech Republic)

Author keywords

Antioxidant; Cymbopogon citratus; Flavonoids; Lemongrass; Oxidized LDL

Indexed keywords

FLAVONOID; HYPOCHOLESTEROLEMIC AGENT; ISOORIENTIN; ISOORIENTIN 2'' O RHAMNOSIDE; ISOORIENTIN 2''-O-RHAMNOSIDE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LUTEOLIN; SWERTIAJAPONIN;

ARTICLE; CHEMISTRY; CYMBOPOGON; DRUG EFFECT; HUMAN; LIPID PEROXIDATION; METABOLISM;

ANTICHOLESTEREMIC AGENTS; CHOLESTEROL, LDL; CYMBOPOGON; FLAVONOIDS; HUMANS; LIPID PEROXIDATION; LUTEOLIN;

EID: 70350504540     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules14103906     Document Type: Article

References (23)

1. Scheibmeir, H.D.; Christensen, K.; Whitaker, S.H.; Jegaethesan, J.; Clancy, R.; Pierce, J.D. A review of free radicals and antioxidants for critical care nurses. Intensive Crit. Care Nurs. 2005, 21, 24-28.
2. Aviram, M. Flavonoids-rich nutrients with potent antioxidant activity prevent atherosclerosis development: The licorice example. Int. Congr. Ser. 2004, 1252, 320-327.
3. Fuhrman, B.; Volkova, N.; Kaplan, M.; Presser, D.; Attias, J.; Hayek, T.; Aviram, M. Antiatherosclerotic effects of licorice extract supplementation on hypercholesterolemic patients: increased resistance of LDL to atherogenic modifications, reduced plasma lipid levels, and decreased systolic blood pressure. Nutrition 2002, 18, 268-273.
4. Meydani, M. Vitamin E and atherosclerosis: Beyond prevention of LDL oxidation. J. Nutr. 2001, 131, 366S-368S.
5. Lamarche, B.; Tchernof, A.; Moorjani, S.; Cantin, B.; Dagenais, G.R.; Lupien, P.J.; Despres, J.P. Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Prospective results from the Quebec Cardiovascular Study. Circulation 1997, 95, 69-75. (Pubitemid 27029945)
6. Ferns, G.A.; Lamb, D.J. What does the lipoprotein oxidation phenomenon mean? Biochem. Soc. Trans. 2004, 32, 160-163.
7. Liu, G.X.; Ou, D.M.; Li, L.X.; Chen, L.X.; Huang, H.L.; Liao, D.F.; Tang, C.S. Probucol inhibits oxidized-low density lipoprotein-induced adhesion of monocytes to endothelial cells in vitro. Acta Pharmacol. Sin. 2002, 23, 516-522.
8. Belinky, P.A.; Aviram, M.; Fuhrman, B.; Rosenblat, M.; Vaya, J. The antioxidative effects of the isoflavan glabridin on endogenous constituents of LDL during its oxidation. Atherosclerosis 1998, 137, 49-61.
9. Vaya, J.; Mahmood, S.; Goldblum, A.; Aviram, M.; Volkova, N.; Shaalan, A.; Musa, R.; Tamir, S. Inhibition of LDL oxidation by flavonoids in relation to their structure and calculated enthalpy. Phytochemistry 2003, 62, 89-99.
10. WHO/FAO. Diet, nutrition, and the prevention of chronic diseases. World Health Organization: Geneva, Switzerland, 2003.
11. Cheel, J.; Theoduloz, C.; Rodriguez, J.; Schmeda-Hirschmann, G. Free radical scavengers and antioxidants from Lemongrass (Cymbopogon citratus (DC.) Stapf.). J. Agric. Food Chem. 2005, 53, 2511-2517.
12. Ko, F.N.; Chu, C.C.; Lin, C.N.; Chang, C.C.; Teng, C.M. Isoorientin-6"-O-glucoside, a watersoluble antioxidant isolated from Gentiana arisanensis. Biochim. Biophys. Acta 1998, 1389, 81-90.
13. Chattopadhyay, A.; Bandyopadhyay, D. Vitamin E in the prevention of ischemic heart disease. Pharmacol. Rep. 2006, 58, 179-187.
14. Upston, J.M.; Kritharides, L.; Stocker, R. The role of vitamin E in atherosclerosis. Prog. Lipid. Res. 2003, 42, 405-422.
15. Fernandez, M.T.; Mira, M.L.; Florencio, M.H.; Jennings, K.R. Iron and copper chelation by flavonoids: an electrospray mass spectrometry study. J. Inorg. Biochem. 2002, 92, 105-111.
16. 2+-mediated oxidative modification of human low density lipoproteins. Eur. J. Nutr. 2005, 44, 422-428.
17. Rice-Evans, C. Flavonoids and isoflavones: absorption, metabolism, and bioactivity. Free Radic. Biol. Med. 2004, 36, 827-828.
18. Skibola, C.F.; Smith, M.T. Potential health impacts of excessive flavonoid intake. Free Radic. Biol. Med. 2000, 29, 375-383.
19. Li, D.; Wang, Q.; Yuan, Z.F.; Zhang, L.; Xu, L.; Cui, Y.; Duan, K. Pharmacokinetics and tissue distribution study of orientin in rat by liquid chromatography. J. Pharm. Biomed. Anal. 2008, 47, 429-434.
20. Galle, J.; Wanner, C. Oxidized LDL and Lp (a): Preparation, Modification and Analysis: Methods in Molecular Biology. In Free Radical and Antioxidants Protocols; Armstrong, D., Ed.; Humana Press Inc.: Totowa, NJ, USA, 1998; Vol. 108, pp. 119-130.
21. Lowry, O.H.; Rosebrough, N.J.; Farr, A.L.; Randall, R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951, 193, 265-275.
22. Esterbauer, H.; Striegl, G.; Puhl, H.; Rotheneder, M. Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Radic. Res. Commun. 1989, 6, 67-75.
23. Leung, L.K.; Su, Y.; Chen, R.; Zhang, Z.; Huang, Y.; Chen, Z.Y. Theaflavins in black tea and catechins in green tea are equally effective antioxidants. J. Nutr. 2001, 131, 2248-2251.